Milrinone Versus Sildenafil in Treatment of PPHN in Neonates
Milrinone Versus Sildenafil in Treatment of PPHN in Neonates
Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.
40 neonates with PPHN, met inclusion criteria, randomly assigned to 2 groups, each includes 20, first group received intravenous milrinone and second group received nasogastric sildenafil. both groups receive other supportive care.
Inclusion Criteria:
Exclusion Criteria: